Risk factors

Korro Bio (KRRO) risk factors

Item 1A of every Korro Bio, Inc. 10-K on file, and what changed from one year to the next.

Open KRRO in Gloomberb →
  • FY2025 10-K risk factors

    94 risks, 8 new, 13 dropped, 33 reworded since the prior year. Korro Bio faces severe concentration risk on lead candidate KRRO-121 targeting hyperammonemia, with a planned IND filing in the second half of 2026.

    Filed Mar 12, 2026
  • FY2024 10-K risk factors

    99 risks. Korro Bio faces substantial operating losses and an accumulated deficit of $266.6 million as of December 31, 2024.

    Filed Mar 18, 2025